Lihan Zhou, CEO and Co-Founder of Mirxes, a Singapore-based bio-test company, discusses the company's Hong Kong IPO and ...

Theodore Shou, CEO of Yiyi Capital, discusses the recent strong performance of the IPO market in Hong Kong and says that the valuation premium between mainland China and Hong Kong stocks would narrow ...

The Chinese drugmaker raised HK$9.74 billion, equivalent to US$1.25 billion, in net proceeds, making it one of Hong Kong's largest IPOs so far this year. The stock was priced at HK$44.05 per share, ...

Shares of Jiangsu Hengrui Pharmaceuticals soared Friday morning, as more companies seek to tap Hong Kong’s capital markets.

Robin Zeng’s high-stakes bets—from quitting his first job to founding CATL—have reshaped the global EV battery market.

Yatsen's shares now trade more than 50% below their IPO price, and its price to sales ratio (P/S) of 0.99 is well behind the ...

The fintech firm is betting on global expansion and AI-driven financial infrastructure to anchor its next phase of growth.

Mod­er­na pulls BLA for its Covid-flu shot: The com­pa­ny sug­gest­ed on its most re­cent … Get free access to a limited ...

Trade tensions with the US show little sign of denting faith in China's EV sector, after battery-maker CATL pulled off the ...

Ultra High Point, which aims to offer customized healthcare information-technology solutions and services to hospitals in Hong Kong, filed to go public in the U.S. The company said it plans to offer a ...

China hawks in Congress are pressuring executives at the financial giants JPMorgan Chase and Bank of America to back out of ...

With total assets of $53.7 billion, FWD Group has launched its fourth IPO attempt in Hong Kong, tapping into surging investor ...